We examined protein kinase C (PKC) activity in Ca2+‐dependent PKC (Ca2+‐dependent PKC activities) and Ca2+‐independent PKC (Ca2+‐independent PKC activities) assay conditions in brains from Alzheimer's disease (AD) patients and age‐matched controls. In cytosolic and membranous fractions, Ca2+‐dependent and Ca2+‐independent PKC activities were significantly lower in AD brain than in control brain. In particular, reduction of Ca2+‐independent PKC activity in the membranous fraction of AD brain was most enhanced when cardiolipin, the optimal stimulator of PKC‐ε, was used in the assay; whereas Ca2+‐independent PKC activity stimulated by phosphatidylinositol, the optimal stimulator of PKC‐δ, was not significantly reduced in AD. Further studies on the protein levels of Ca2+‐independent PKC‐δ, PKC‐ε, and PKC‐ζ in AD brain revealed reduction of the PKC‐ε level in both cytosolic and membranous fractions, although PKC‐δ and PKC‐ζ levels were not changed. These findings indicated that Ca2+‐dependent and Ca2+‐independent PKC are changed in AD, and that among Ca2+‐independent PKC isozymes, the alteration of PKC‐ε is a specific event in AD brain, suggesting its crucial role in AD pathophysiology.